ST. PAUL, Minn.--(BUSINESS WIRE)--Smiths Medical, a leading global medical device manufacturer, announced today it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to launch ...
Rehospitalization following immune-related adverse events from immune checkpoint inhibitors: A retrospective chart review. This is an ASCO Meeting Abstract from the 2025 ASCO Quality Care Symposium.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results